Exploring how office-based methadone prescribing could improve treatment for opioid use disorder in New York.
Simulating the Impact of Office-Based Methadone Prescribing and Pharmacy Dispensing on OUD Treatment and Overdose in New York State: An Agent-Based Modeling Approach
This study is looking at how different ways of providing methadone treatment for opioid use disorder in New York could make it easier for people to get help and lower the chances of overdoses, so that lawmakers can find the best options for everyone.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11009694 on NIH RePORTER |
What this research studies
This research investigates the potential impact of different methadone treatment delivery methods for opioid use disorder (OUD) in New York State. By using computer simulations, the study will model various policy scenarios, including office-based prescribing and pharmacy dispensing, to understand how these changes could improve access to care and reduce overdose risks. The goal is to provide evidence that can inform lawmakers about the most effective strategies for delivering methadone treatment. Patients may benefit from more accessible treatment options if these policies are implemented successfully.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with opioid use disorder who may benefit from more accessible methadone treatment options.
Not a fit: Patients who are not affected by opioid use disorder or those who do not require methadone treatment may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to methadone treatment, ultimately reducing overdose rates among patients with opioid use disorder.
How similar studies have performed: Other research has shown that improving access to methadone treatment can significantly reduce overdose rates, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Krawczyk, Noa — New York University School of Medicine
- Study coordinator: Krawczyk, Noa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.